Investors Buy C.R. Bard Inc. (BCR) on Weakness
Investors bought shares of C.R. Bard Inc. (NYSE:BCR) on weakness during trading on Monday. $17.41 million flowed into the stock on the tick-up and $10.62 million flowed out of the stock on the tick-down, for a money net flow of $6.79 million into the stock. Of all stocks tracked, C.R. Bard had the 26th highest net in-flow for the day. C.R. Bard traded down ($0.29) for the day and closed at $221.21
Several brokerages have recently commented on BCR. Bank of America Corp. downgraded shares of C.R. Bard from a “buy” rating to a “neutral” rating in a research note on Friday, July 8th. JPMorgan Chase & Co. boosted their target price on shares of C.R. Bard from $214.00 to $225.00 and gave the company a “neutral” rating in a research note on Wednesday, July 27th. BMO Capital Markets reiterated a “hold” rating and set a $240.00 price target on shares of C.R. Bard in a research report on Wednesday, July 27th. Jefferies Group upped their price target on shares of C.R. Bard from $215.00 to $237.00 and gave the stock a “hold” rating in a research report on Wednesday, July 27th. Finally, Citigroup Inc. upped their price target on shares of C.R. Bard from $241.00 to $265.00 and gave the stock a “buy” rating in a research report on Wednesday, July 27th. Thirteen analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $232.85.
The company has a market capitalization of $16.25 billion and a P/E ratio of 51.44. The company’s 50 day moving average price is $223.14 and its 200 day moving average price is $214.80.
C.R. Bard (NYSE:BCR) last issued its quarterly earnings results on Tuesday, July 26th. The company reported $2.54 EPS for the quarter, topping the Zacks’ consensus estimate of $2.47 by $0.07. The company earned $931.50 million during the quarter, compared to the consensus estimate of $915.22 million. The firm’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.27 EPS. Equities analysts predict that C.R. Bard Inc. will post $10.17 earnings per share for the current year.
An institutional investor recently raised its position in C.R. Bard stock. Schwab Charles Investment Management Inc. increased its position in C.R. Bard Inc. (NYSE:BCR) by 4.7% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 471,693 shares of the company’s stock after buying an additional 21,246 shares during the period. Schwab Charles Investment Management Inc. owned 0.64% of C.R. Bard worth $89,358,000 at the end of the most recent reporting period.
C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.